Benefit of Early versus Deferred Antiretroviral Therapy on Progression of Liver Fibrosis among People with HIV in the START Randomized Trial

The role of antiretroviral therapy (ART) in reducing or contributing to liver fibrosis in persons with human immunodeficiency virus (HIV) is unclear. We evaluated participants in the Strategic Timing of AntiRetroviral Treatment (START) trial for liver fibrosis using the AST to Platelet Ratio Index (...

Descripción completa

Detalles Bibliográficos
Autores principales: Dharan, Nila J., Neuhaus, Jacqueline, Rockstroh, Juergen K., Peters, Lars, Gordin, Fred, Arenas‐Pinto, Alejandro, Emerson, Carol, Marks, Kristen, Hidalgo, Jose, Sarmento‐Castro, Rui, Stephan, Christoph, Kumarasamy, Nagalingeswaran, Emery, Sean, Matthews, Gail V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393919/
https://www.ncbi.nlm.nih.gov/pubmed/30298608
http://dx.doi.org/10.1002/hep.30296

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393919/
https://www.ncbi.nlm.nih.gov/pubmed/30298608
http://dx.doi.org/10.1002/hep.30296

Ejemplares similares